Drug Screening Program Sample Clauses

Drug Screening Program. A. The Employer shall post a notice of the department's drug testing policy on bulletin boards in areas that are accessible to employees. B. Urine testing of employees can be an effective means by which to identify those in need of counseling, treatment, or disciplinary action. The testing program is intended to supplement, not replace, other means by which the use of drugs can be detected. C. Employees will be required to participate in the drug testing program under the following conditions: (1) When there is a reasonable suspicion that an employee is using, under the influence of or in possession of illegal drugs, or is using or under the influence of alcohol while on duty, or that the employee is abusing alcohol or illegal drugs and the abuse either adversely affects his/her job performance or represents a threat to the safety of the employee, coworkers, or the public. Reasonable suspicion drug/alcohol testing can be ordered by any supervisor with the approval of a commanding officer (lieutenant or above). An immediate supervisor requesting a drug/alcohol test founded on reasonable suspicion should consider among such facts and inferences: (a) Observable behavior while at work, such as direct observation of drug/alcohol use or of the physical symptoms or manifestations of being under the influence of a drug/alcohol. (b) Abnormal conduct or erratic behavior while at work or a significant deterioration in work performance. (c) A report of drug/alcohol use provided by a reliable and credible source which has been independently corroborated with observable behavior. (d) Evidence that the employee has tampered with a drug/alcohol test during his/her employment with the Employer. (e) Information that an employee has caused or contributed to an accident while at work combined with observable behavior indicating the possibility that drug/alcohol usage may be involved. (f) Evidence that an employee has used, possessed, sold, solicited, or transferred drugs, or used or been under the influence of alcohol, while working or while on the Employer's premises or while operating the Employer's vehicle, machinery, or equipment. (2) Following a serious accident or incident in which safety precautions were violated or unusually careless acts were performed and there is reasonable suspicion to believe these actions were the result of using drugs.
Sample 1Sample 2Sample 3See All (9)
AutoNDA by SimpleDocs
Drug Screening Program. A. The Employer shall post a notice of the department's drug testing policy on bulletin boards in areas that are accessible to employees. B. Urine testing of employees can be an effective means by which to identify those in need of counseling, treatment, or disciplinary action. The testing program is intended to supplement, not replace, other means by which the use of drugs can be detected. C. Employees will be required to participate in the drug testing program under the following conditions:
Sample 1Sample 2Sample 3See All (8)
Drug Screening Program. After negotiations with the Union about the effects on police officers under this Agreement, the City has adopted a drug screening program which is attached as Exhibit H to this Agreement. To the extent such program applies to police officers under this Agreement, the program, which is a part of Class 3 Breath Test Operator C.A.D./Dispatch Desk Chemical Spray Instructors Defensive Tactics Instructors Driving Instructors Evidence Technician Field Training Officer Hostage Negotiators Motor Carrier Sniper Range Officer/Firearms Instructors Traffic Accident Investigators Motorcycle Operators Pepperball Instructors Computer Forensics TASER Instructor K-9 Instructor Alcohol Traffic Enforcement Mountain Bike The Optical Plan provided in Article IX is the Health Application Network Plan. Consistent with the provisions of Article IX, employees shall elect as part of an insurance option outlined in Article IX, employees shall elect as part of a n insurance option outlined in Article IX, either HAN Plan I or II. HAN Panel Provider Non-Panel Provider Examination 100% $20.00 Lenses (Pair) $65.00 $45.00 Single Vision Bifocal $90.00 $49.00 Trifocal $100.00 $55.00 Lenticular $115.00 $65.00 Frames $90.00 $45.00 Contact Lenses $130.00 $90.00 The benefits summarized below and more particularly described on the following pages are separate from Medical Expense Benefits. Benefits for each of an employee's insured dependents will be on the same basis as his own. PLAN I services; 80% of Covered Dental Expenses for Type II services; 60% of covered Dental Expenses for Type III. This maximum applies separately to each insured family member. PLAN II services; 80% of Covered Dental Expenses for Type II services; 60% of covered Dental Expenses for Type III. This maximum applies separately to each insured family member. Schedule "C" (Continued) Covered Dental Expenses, as previously defined, also include charges for orthodontic diagnostic procedures and treatment consisting of surgical therapy, appliance therapy, and functional/myofunctional therapy (including related oral examinations, surgery and extractions) for children under 23 years of age. The rate of reimbursement for these charges will be 50% of the usual, reasonable and customary charges. Effective July 1, 1999 - The maximum benefit will be $1,800.00 for all such expenses incurred during the lifetime of those insured. The term "orthodontic treatment" means preventive and corrective treatment of all those dental irregularities...
Sample 1
Drug Screening Program. After negotiations with the Union about the effects on police officers under this Agreement, the City has adopted a drug screening program which is attached as Exhibit H to this Agreement. To the extent such program applies to police officers under this Agreement, the program, which is a part of Group: Letter Code: Police Officers G 2% PAY GRADE POSITION A B C D E G H I Minumum 6 Months 12 Months 18 Months 24 Months 36 Months 48 Months 60 Months 01 (I) Police Officer H 21.165 23.595 26.009 28.437 30.852 33.240 33.772 W 846.600 943.800 1,040.360 1,137.480 1,234.080 1,329.600 1,350.880 B 1,693.200 1,887.600 2,080.720 2,274.960 2,468.160 2,659.200 2,701.760 M 3,668.600 4,089.800 4,508.227 4,929.080 5,347.680 5,761.600 5,853.813 A 44,023.200 49,077.600 54,098.720 59,148.960 64,172.160 69,139.200 70,245.760 02 (II) Officer/Sergeant H 33.712 34.520 35.285 36.179 Youth Officer Sergeant W 1,348.480 1,380.800 1,411.400 1,447.160 School Liaison Officer Sgt. B 2,696.960 2,761.600 2,822.800 2,894.320 M 5,843.413 5,983.467 6,116.067 6,271.027 A 70,120.960 71,801.600 73,392.800 75,252.320 Group: Letter Code: Police Officers G 2% PAY GRADE POSITION A B C D E G H I Minumum 6 Months 12 Months 18 Months 24 Months 36 Months 48 Months 60 Months 01 (I) Police Officer H 21.588 24.067 26.529 29.006 31.469 33.905 34.447 W 863.520 962.680 1,061.160 1,160.240 1,258.760 1,356.200 1,377.880 B 1,727.040 1,925.360 2,122.320 2,320.480 2,517.520 2,712.400 2,755.760 M 3,741.920 4,171.613 4,598.360 5,027.707 5,454.627 5,876.867 5,970.813 A 44,903.040 50,059.360 55,180.320 60,332.480 65,455.520 70,522.400 71,649.760 02 (II) Officer/Sergeant H 34.386 35.210 35.991 36.903 Youth Officer Sergeant W 1,375.440 1,408.400 1,439.640 1,476.120 School Liaison Officer Sgt. B 2,750.880 2,816.800 2,879.280 2,952.240 M 5,960.240 6,103.067 6,238.440 6,396.520 A 71,522.880 73,236.800 74,861.280 76,758.240 Group: Letter Code: Police Officers G 2% PAY GRADE POSITION A B C D E G H I Minumum 6 Months 12 Months 18 Months 24 Months 36 Months 48 Months 60 Months 01 (I) Police Officer H 22.020 24.548 27.060 29.586 32.098 34.583 35.136 W 880.800 981.920 1,082.400 1,183.440 1,283.920 1,383.320 1,405.440 B 1,761.600 1,963.840 2,164.800 2,366.880 2,567.840 2,766.640 2,810.880 M 3,816.800 4,254.987 4,690.400 5,128.240 5,563.653 5,994.387 6,090.240 A 45,801.600 51,059.840 56,284.800 61,538.880 66,763.840 71,932.640 73,082.880 02 (II) Officer/Sergeant H 35.074 35.914 36.711 37.641 Youth Officer Sergeant W 1,402.960 1,436....
Sample 1
Drug Screening Program. A. The Employer shall post a notice of the department's drug testing policy on bulletin boards in areas that are accessible to employees. B. Urine testing of employees can be an effective means by which to identify those in need of counseling, treatment, or disciplinary action. The testing program is intended to supplement, not replace, other means by which the use of drugs can be detected. C. Employees will be required to participate in the drug testing program under the following conditions: (1) When there is a reasonable suspicion that an employee is using, under the influence of or in possession of illegal drugs, or is using or under the influence of alcohol while on duty, or that the employee is abusing alcohol or illegal drugs and the abuse either adversely affects his/her job performance or represents a threat to the safety of the employee, coworkers, or the public. Reasonable suspicion drug/alcohol testing can be ordered by any supervisor with the approval of a commanding officer (lieutenant or above). An immediate supervisor requesting a drug/alcohol test founded on reasonable suspicion should consider among such facts and inferences: (a) Observable behavior while at work, such as direct (b) Abnormal conduct or erratic behavior while at work or a significant deterioration in work performance. (c) A report of drug/alcohol use provided by a reliable and credible source which has been independently corroborated with observable behavior. (d) Evidence that the employee has tampered with a drug/alcohol test during his/her employment with the Employer. (e) Information that an employee has caused or contributed to an accident while at work combined with observable behavior indicating the possibility that drug/alcohol usage may be involved. (f) Evidence that an employee has used, possessed, sold, solicited, or transferred drugs, or used or been under the influence of alcohol, while working or while on the Employer's premises or while operating the Employer's vehicle, machinery, or equipment. (2) Following a serious accident or incident in which safety precautions were violated or unusually careless acts were performed and there is reasonable suspicion to believe these actions were the result of using drugs.
Sample 1
Drug Screening Program. Respondent shall submit to the Board’s drug screening program and agrees to comply with all requirements of the drug-screening program. Respondent shall provide random blood or urine specimens when required. Respondent shall ensure that all urine samples are appropriately witnessed as required by the drug screening program and agrees that samples that are not visually witnessed will be considered invalid. Respondent understands that the “incidental” use of alcohol (i.e. in mouthwash, hand cleaning gel, or over the counter medications containing alcohol) may cause a positive test that cannot be differentiated from intentional ingestion. Respondent agrees that all confirmed, positive tests will be presumed valid and that he has the burden of proof to establish that a positive report was erroneous. Respondent shall also provide random blood or urine specimens on demand by an agent of the Board. The specimens collected pursuant to this paragraph shall be used for drug and alcohol screening, all costs of which shall be paid by Respondent.
Sample 1
Drug Screening Program. 38.1: After negotiations with the Union about the effects on police officers under this Agreement, the City has adopted a drug screening program which is attached as Exhibit H to this Agreement. To the extent such program applies to police officers under this Agreement, the program, which is a part of The City's Rules and Regulations, is incorporated into this Agreement.
Sample 1
AutoNDA by SimpleDocs

Related to Drug Screening Program

  • Development Program RWJPRI shall be [**] and have [**] in consultation with the JDAC, to select LICENSED COMPOUNDS which shall then be designated PRODUCTS for further DEVELOPMENT by RWJPRI and marketing by ORTHO and its AFFILIATES. RWJPRI shall provide KOSAN with written notice of its decision to select a LICENSED COMPOUND for DEVELOPMENT. Once a PRODUCT has been selected for further DEVELOPMENT, RWJPRI, with the advice of the JDAC, shall have the [**] right to develop the PRODUCT through STAGES O, I, II and III and shall have the [**] right to prepare and file, and shall be the owner of, all applications for MARKETING AUTHORIZATION throughout the world. During such DEVELOPMENT efforts, KOSAN will assist RWJPRI as may be mutually agreed, at RWJPRI's expense, in chemical development, formulation development, production of labeled material and production of sufficient quantities of material for STAGE O and initial STAGE I studies. RWJPRI shall exercise diligent efforts, commensurate with the efforts it would normally exercise for products with similar potential sales volume and consistent with its overall business strategy, in developing such PRODUCT in accordance with the DEVELOPMENT PLAN established by RWJPRI. In the course of such efforts RWJPRI shall, either directly or through an AFFILIATE or SUBLICENSEE to which the license shall have been extended, take appropriate steps including the following: (i) in consultation with the JDAC, select certain LICENSED COMPOUNDS for STAGE O DEVELOPMENT; and (ii) establish and maintain a program reasonably designed, funded and resourced to obtain information adequate to enable the preparation and filing with an appropriate and properly empowered national regulatory authority all necessary documentation, data and [**] CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. other evidence required for IND non-rejection to commence and conduct human clinical trials of such PRODUCT. (iii) proceed following IND non-rejection to commence PHASE I, II, and III clinical trials, associated studies and such other work which RWJPRI reasonably deems to be required for subsequent inclusion in filings for MARKETING AUTHORIZATION; (iv) after such submissions are filed prosecute such submissions and file all reasonably necessary, reports and respond to all reasonable requests from the pertinent regulatory, authorities for information, data, samples, tests and the like.

  • Training Program It is agreed that there shall be an Apprenticeship Training Program, the provisions of which are set forth in Exhibit "D", which is attached hereto and forms part of this Agreement.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Concession Area, including its abandonment.

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act. (B) All classes covered by this Agreement are designated special risk classes for drug testing purposes. Special risk means employees who are required as a condition of employment to be certified under Chapter 633 or Chapter 943, F.S. (C) An employee shall have the right to grieve any disciplinary action taken under section 112.0455, the Drug-Free Workplace Act, subject to the limitations on the grievability of disciplinary actions in Article 10. If an employee is not disciplined but is denied a demotion, reassignment, or promotion as a result of a positive confirmed drug test, the employee shall have the right to grieve such action in accordance with Article 6.

  • Research Program The term “Research Program” shall mean the research program to be undertaken by TSRI under the direction and control of the Principal Investigator as expressly set forth on Exhibit A hereto.

  • Commercialization Plan (a) Not later than three [***] after submission of Regulatory Filings for each Product in each country of the Territory, Licensee will provide to the JCC for review its initial Commercialization Plan for each Product for each country in the Territory. Such initial Commercialization Plan will describe Licensee’s plans for activities to be conducted for such Product for such country. Each Commercialization Plan shall include the details of obligations to be performed by Licensee to achieve the specific activities that are applicable to the stage of [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Commercialization (e.g., pre-launch, launch planning, launch, or post-launch) of the applicable Product during the time period covered by such Commercialization Plan and subsequent time periods. (b) Prior to the First Commercial Sale for such Product in such country, Licensee will provide to the JCC for review an updated Commercialization Plan for such Product for such country. Such updated Commercialization Plan will include, but not be limited to, Licensee’s updated plans for activities to be conducted for such Product for such country prior to launch as well as activities to be conducted in connection with such launch. (c) Promptly after each anniversary of the First Commercial Sale of such Product during the Term, Licensee will provide to the JCC for review updated Commercialization Plans for such Product for such country. Such further updated Commercialization Plan will include, but not be limited to, Licensee’s plans for Commercialization activities for such Product and such country for the twelve (12) month period following the date of delivery of such Commercialization Plan. No Commercialization Plan may be implemented by Licensee if [***]. Each Commercialization Plan shall be consistent with and shall not contradict the terms of this Agreement [***], and in the event of any inconsistency between the Commercialization Plan and this Agreement, the terms of this Agreement shall prevail. Notwithstanding the foregoing, if a [***], Licensee shall [***] and shall promptly [***].

  • Clinical 1.1 Provides comprehensive evidence based nursing care and individual case management to a specific group of patients/clients including assessment, intervention and evaluation. 1.2 Undertakes clinical shifts at the direction of senior staff and the Nursing Director including participation on the on-call/after-hours/weekend roster if required. 1.3 Responsible and accountable for patient safety and quality of care through planning, coordinating, performing, facilitating, and evaluating the delivery of patient care relating to a particular group of patients, clients or staff in the practice setting. 1.4 Monitors, reviews and reports upon the standard of nursing practice to ensure that colleagues are working within the scope of nursing practice, following appropriate clinical pathways, policies, procedures and adopting a risk management approach in patient care delivery. 1.5 Participates in xxxx rounds/case conferences as appropriate. 1.6 Educates patients/carers in post discharge management and organises discharge summaries/referrals to other services, as appropriate. 1.7 Supports and liaises with patients, carers, colleagues, medical, nursing, allied health, support staff, external agencies and the private sector to provide coordinated multidisciplinary care. 1.8 Completes clinical documentation and undertakes other administrative/management tasks as required. 1.9 Participates in departmental and other meetings as required to meet organisational and service objectives. 1.10 Develops and seeks to implement change utilising expert clinical knowledge through research and evidence based best practice. 1.11 Monitors and maintains availability of consumable stock. 1.12 Complies with and demonstrates a positive commitment to Regulations, Acts and Policies relevant to nursing including the Code of Ethics for Nurses in Australia, the Code of Conduct for Nurses in Australia, the National Competency Standards for the Registered Nurse and the Poisons Act 2014 and Medicines and Poisons Regulations 2016. 1.13 Promotes and participates in team building and decision making. 1.14 Responsible for the clinical supervision of nurses at Level 1 and/or Enrolled Nurses/ Assistants in Nursing under their supervision.

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

  • Technology Research Analyst Job# 1810 General Characteristics

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!